274 related articles for article (PubMed ID: 2888625)
1. Effect of cytochrome P-450 and flavin-containing monooxygenase modifying factors on the in vitro metabolism of amiodarone by rat and rabbit.
Young RA; Mehendale HM
Drug Metab Dispos; 1987; 15(4):511-7. PubMed ID: 2888625
[TBL] [Abstract][Full Text] [Related]
2. In vitro metabolism of amiodarone by rabbit and rat liver and small intestine.
Young RA; Mehendale HM
Drug Metab Dispos; 1986; 14(4):423-9. PubMed ID: 2873989
[TBL] [Abstract][Full Text] [Related]
3. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. I. Cytochrome P-450-catalyzed N-demethylation and 4-hydroxylation.
Mani C; Gelboin HV; Park SS; Pearce R; Parkinson A; Kupfer D
Drug Metab Dispos; 1993; 21(4):645-56. PubMed ID: 8104124
[TBL] [Abstract][Full Text] [Related]
4. Determination of the enzyme(s) involved in the metabolism of amiodarone in liver and intestine of rat: the contribution of cytochrome P450 3A isoforms.
Shayeganpour A; El-Kadi AO; Brocks DR
Drug Metab Dispos; 2006 Jan; 34(1):43-50. PubMed ID: 16204463
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro biotransformation of theobromine by phenobarbital- and 3-methylcholanthrene-inducible cytochrome P-450 monooxygenases in rat liver. Role of thiol compounds.
Shively CA; Vesell ES
Drug Metab Dispos; 1987; 15(2):217-24. PubMed ID: 2882982
[TBL] [Abstract][Full Text] [Related]
6. Role of isozymes of cytochrome P-450 in the metabolism of N,N-dimethyl-4-aminoazobenzene in the rat.
Levine WG; Lu AY
Drug Metab Dispos; 1982; 10(2):102-9. PubMed ID: 6124393
[TBL] [Abstract][Full Text] [Related]
7. Immunological identification and effects of 3-methylcholanthrene and phenobarbital on rat pulmonary cytochrome P-450.
Keith IM; Olson EB; Wilson NM; Jefcoate CR
Cancer Res; 1987 Apr; 47(7):1878-82. PubMed ID: 3545456
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of mono-oxygenase and oxidase activity of rat-hepatic cytochrome P-450 by H2-receptor blockers.
Bast A; Savenije-Chapel EM; Kroes BH
Xenobiotica; 1984 May; 14(5):399-408. PubMed ID: 6089451
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P-450-mediated activation and irreversible binding of the antiestrogen tamoxifen to proteins in rat and human liver: possible involvement of flavin-containing monooxygenases in tamoxifen activation.
Mani C; Kupfer D
Cancer Res; 1991 Nov; 51(22):6052-8. PubMed ID: 1933868
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme-specific complexation of cytochrome P-450 and inhibition kinetics.
Reidy GF; Mehta I; Murray M
Mol Pharmacol; 1989 May; 35(5):736-43. PubMed ID: 2725477
[TBL] [Abstract][Full Text] [Related]
11. Biotransformation of N,N',N''-triethylenethiophosphoramide: oxidative desulfuration to yield N,N',N''-triethylenephosphoramide associated with suicide inactivation of a phenobarbital-inducible hepatic P-450 monooxygenase.
Ng SF; Waxman DJ
Cancer Res; 1990 Feb; 50(3):464-71. PubMed ID: 2105156
[TBL] [Abstract][Full Text] [Related]
12. Role of P-450c in the formation of a reactive intermediate of chlorotrianisene (TACE) by hepatic microsomes from methylcholanthrene-treated rats.
Juedes MJ; Kupfer D
Drug Metab Dispos; 1990; 18(2):131-7. PubMed ID: 1971562
[TBL] [Abstract][Full Text] [Related]
13. Inhibition and induction of rabbit liver microsomal cytochrome P-450 by pyridine.
Kaul KL; Novak RF
J Pharmacol Exp Ther; 1987 Oct; 243(1):384-90. PubMed ID: 3668864
[TBL] [Abstract][Full Text] [Related]
14. Immunochemical detection and quantitation of microsomal cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate:cytochrome P-450 reductase in the rat ventral prostate.
Haaparanta T; Halpert J; Glaumann H; Gustafsson JA
Cancer Res; 1983 Nov; 43(11):5131-7. PubMed ID: 6413054
[TBL] [Abstract][Full Text] [Related]
15. Relation between hepatic microsomal metabolism of N-nitrosamines and cytochrome P-450 species.
Kawanishi T; Ohno Y; Takahashi A; Takanaka A; Kasuya Y; Omori Y
Biochem Pharmacol; 1985 Apr; 34(7):919-24. PubMed ID: 3985997
[TBL] [Abstract][Full Text] [Related]
16. Interaction of constitutive and phenobarbital-induced cytochrome P-450 isozymes during the sequential oxidation of benzphetamine. Explanation for the difference in benzphetamine-induced hydrogen peroxide production and 455-nm complex formation in microsomes from untreated and phenobarbital-treated rats.
Jeffery EH; Mannering GJ
Mol Pharmacol; 1983 May; 23(3):748-57. PubMed ID: 6865917
[TBL] [Abstract][Full Text] [Related]
17. Cytochrome P-450- and flavin-containing monooxygenase-catalyzed formation of the carcinogen N-hydroxy-2-aminofluorene and its covalent binding to nuclear DNA.
Frederick CB; Mays JB; Ziegler DM; Guengerich FP; Kadlubar FF
Cancer Res; 1982 Jul; 42(7):2671-7. PubMed ID: 7083159
[TBL] [Abstract][Full Text] [Related]
18. Influence of cigarette smoke on antipyrine metabolite formation in rats.
Nakagawa A; Chiba K; Ishizaki T; Nakamura K
Res Commun Chem Pathol Pharmacol; 1983 Sep; 41(3):473-91. PubMed ID: 6635330
[TBL] [Abstract][Full Text] [Related]
19. [Resistance of different forms of rat liver cytochrome P-450 to influence destabilizing microsomal membranes].
Gromova OA; Zakharova NE; Liakhovich VV; Tsyrlov IB
Biull Eksp Biol Med; 1977 May; 83(5):553-5. PubMed ID: 884258
[TBL] [Abstract][Full Text] [Related]
20. Nordihydroguaiaretic acid, an inhibitor of lipoxygenase, also inhibits cytochrome P-450-mediated monooxygenase activity in rat epidermal and hepatic microsomes.
Agarwal R; Wang ZY; Bik DP; Mukhtar H
Drug Metab Dispos; 1991; 19(3):620-4. PubMed ID: 1680628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
